Market News

Horizon Therapeutics Fields Takeover Interest From Pharma Giants

A Horizon Therapeutics exhibit, called ‘Listen to Your Eyes’ in Atlanta last June.Photo: Matt Odom/Associated Press

Drugmaker Horizon Therapeutics PLC is fielding takeover interest, according to people familiar with the matter, as large pharmaceutical companies compete for fast-growing medicines to fuel sales.

A deal for Horizon, which develops medicines for rare and immune diseases, would be big. The company has a market value of almost $18 billion and, with a typical takeover premium, could fetch a price well over $20 billion.

Already a member? Sign In

Sponsored Offers

Most Popular news

Most Popular opinion

Recommended Videos

Energy stocks could double next year even in a flat market, according to Fundstrat’s Tom Lee

Previous article

Kroger, Albertsons CEOs defend grocery tie-up, say deal won’t hurt competition

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in Market News